Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for ACU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -1.068M
March 31, 2026 -16.30M
December 31, 2025 -2.551M
September 30, 2025 -6.78M
June 30, 2025 -1.62M
March 31, 2025 -1.353M
December 31, 2024 -0.5962M
September 30, 2024 -1.351M
June 30, 2024 -9.381M
March 31, 2024 -1.611M
December 31, 2023 11.95M
September 30, 2023 -1.502M
June 30, 2023 -2.32M
March 31, 2023 -0.701M
December 31, 2022 -1.019M
September 30, 2022 -0.838M
June 30, 2022 -11.85M
March 31, 2022 -0.518M
December 31, 2021 -1.581M
September 30, 2021 -1.441M
June 30, 2021 -1.871M
March 31, 2021 -1.48M
December 31, 2020 -9.797M
September 30, 2020 -0.758M
June 30, 2020 -0.726M
Date Value
March 31, 2020 -2.671M
December 31, 2019 -0.5575M
September 30, 2019 -0.364M
June 30, 2019 -0.321M
March 31, 2019 -0.438M
December 31, 2018 -0.9789M
September 30, 2018 -0.433M
June 30, 2018 -0.922M
March 31, 2018 -0.897M
December 31, 2017 -4.745M
September 30, 2017 -0.801M
June 30, 2017 -1.096M
March 31, 2017 -7.737M
December 31, 2016 -0.4901M
September 30, 2016 -0.568M
June 30, 2016 -0.322M
March 31, 2016 -7.43M
December 31, 2015 -0.5146M
September 30, 2015 -0.529M
June 30, 2015 -0.296M
March 31, 2015 -0.574M
December 31, 2014 -0.6224M
September 30, 2014 -0.453M
June 30, 2014 -13.33M
March 31, 2014 -0.79M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Cencora, Inc. -240.15M
Abbott Laboratories -673.00M
Align Technology, Inc. -82.16M
AngioDynamics, Inc. -1.27M
Accuray, Inc. -1.353M